DealsArchimed and Warburg Pincus to exit PolyplusPolyplus is a provider of upstream technologies for cell and gene therapies.ByIrien Joseph31 March 2023•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsEuropeHealthcareTMTTop Stories